Unitedhealth Group Incorporated Stock Price To Earning
| UNH Stock | USD 608.38 1.59 0.26% |
UnitedHealth Group Incorporated fundamentals help investors to digest information that contributes to UnitedHealth Group's financial success or failures. It also enables traders to predict the movement of UnitedHealth Stock. The fundamental analysis module provides a way to measure UnitedHealth Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to UnitedHealth Group stock.
UnitedHealth | Price To Earning |
UnitedHealth Group Incorporated Company Price To Earning Analysis
UnitedHealth Group's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current UnitedHealth Group Price To Earning | 26.34 X |
Most of UnitedHealth Group's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, UnitedHealth Group Incorporated is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
UnitedHealth Price To Earning Driver Correlations
Understanding the fundamental principles of building solid financial models for UnitedHealth Group is extremely important. It helps to project a fair market value of UnitedHealth Stock properly, considering its historical fundamentals such as Price To Earning. Since UnitedHealth Group's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of UnitedHealth Group's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of UnitedHealth Group's interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
UnitedHealth Retained Earnings
Retained Earnings |
|
Based on the latest financial disclosure, UnitedHealth Group Incorporated has a Price To Earning of 26.34 times. This indicator is about the same for the Health Care Providers & Services average (which is currently at 25.84) sector and significantly higher than that of the Health Care industry. The price to earning for all United States stocks is 8.29% higher than that of the company.
UnitedHealth Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses UnitedHealth Group's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of UnitedHealth Group could also be used in its relative valuation, which is a method of valuing UnitedHealth Group by comparing valuation metrics of similar companies.UnitedHealth Group is currently under evaluation in price to earning category among its peers.
UnitedHealth Group ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, UnitedHealth Group's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to UnitedHealth Group's managers, analysts, and investors.Environmental | Governance | Social |
UnitedHealth Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0692 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 599.3 B | ||||
| Shares Outstanding | 920.28 M | ||||
| Shares Owned By Insiders | 0.23 % | ||||
| Shares Owned By Institutions | 90.10 % | ||||
| Number Of Shares Shorted | 8.14 M | ||||
| Price To Earning | 26.34 X | ||||
| Price To Book | 5.91 X | ||||
| Price To Sales | 1.42 X | ||||
| Revenue | 367.53 B | ||||
| Gross Profit | 79.62 B | ||||
| EBITDA | 32.52 B | ||||
| Net Income | 22.38 B | ||||
| Cash And Equivalents | 27.91 B | ||||
| Cash Per Share | 45.51 X | ||||
| Total Debt | 62.54 B | ||||
| Debt To Equity | 0.59 % | ||||
| Current Ratio | 0.78 X | ||||
| Book Value Per Share | 102.42 X | ||||
| Cash Flow From Operations | 29.07 B | ||||
| Short Ratio | 2.21 X | ||||
| Earnings Per Share | 15.35 X | ||||
| Price To Earnings To Growth | 1.65 X | ||||
| Target Price | 626.16 | ||||
| Number Of Employees | 440 K | ||||
| Beta | 0.59 | ||||
| Market Capitalization | 558.42 B | ||||
| Total Asset | 273.72 B | ||||
| Retained Earnings | 95.77 B | ||||
| Working Capital | (20.62 B) | ||||
| Current Asset | 31.64 B | ||||
| Current Liabilities | 42.9 B | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 1.35 % | ||||
| Net Asset | 273.72 B | ||||
| Last Dividend Paid | 7.96 |
About UnitedHealth Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze UnitedHealth Group Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of UnitedHealth Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of UnitedHealth Group Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:Check out UnitedHealth Group Piotroski F Score and UnitedHealth Group Altman Z Score analysis. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.043 | Dividend Share 7.96 | Earnings Share 15.35 | Revenue Per Share 427.221 | Quarterly Revenue Growth 0.092 |
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.